What Is Accelerated Approval?
Accelerated approval is an FDA pathway that allows certain drugs for serious conditions to be approved based on a surrogate endpoint or another intermediate clinical measure that is reasonably likely to predict benefit. In biotech, the pathway matters because it can bring promising therapies to patients sooner when waiting for traditional long-term outcomes would be impractical.